DUBLIN--(BUSINESS WIRE)--The "Stem Cell Manufacturing Market by Product (HSCs, MSCs, iPSCs, ESCs, Instruments, Media, Consumables), Application (Research, Target Identification, Therapy (Autologous, Allogeneic), Cell Banks), End User (Pharma, Hospitals) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global stem cell manufacturing market is projected to reach USD 14.61 Billion by 2023 from USD 10.75 Billion in 2018, at a CAGR of 6.3%.
Factors such as growing public-private investments and funding in stem cell-based research, rising public awareness regarding about the therapeutic potency of stem cell products, development of advanced genomic analysis techniques for quality control during stem cell manufacturing, technological advancements in stem cell manufacturing and preservation, and evolving regulatory frameworks for stem cell therapeutics in the US and Europe are driving the growth of the market.
In 2017, the culture media segment accounted for the largest share of the product market. The large market share of this segment is attributed the rising stem cell research and increasing demand for stem cell therapies.
In 2017, cell and tissue banking applications accounted for the largest share of the application market. The dominant share of this segment is credited to the increasing public demand for cord blood stem cell banking and rising awareness regarding the prospective advantages of stem cell preservation.
In 2017, the pharmaceutical and biotech companies accounted for the largest share of the end-user market. The dominant share of this segment is credited to the rising public-private investments for stem cell-based research, ongoing patent expiry of branded drugs, and increasing patient preference for precision & regenerative medicines.
Key Topics Covered
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Stem Cell Manufacturing Market, By Product
7 Stem Cell Manufacturing Market, By Application
8 Stem Cell Manufacturing Market, By End-User
9 Stem Cell Manufacturing Market, By Region
10 Competitive Landscape
11 Company Profiles
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories
- Cellular Dynamics International (Subsidiary of Fujifilm Holdings Corporation)
- Holostem Terapie Avanzate
- Lonza Group
- Merck Group
- Miltenyi Biotec
- Osiris Therapeutics
- Pluristem Therapeutics
- Stemcell Technologies
- Takara Bio Group
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/fxgx9v/global_stem_cell?w=4